English Français Español 中文 العربية

Eventos Noticias Análisis Organizadores

Marketing de EventosPublica, promociona y haz crecer tus eventos ante una audiencia B2B global.
Comunicado de PrensaDistribuye anuncios oficiales a profesionales del sector en todo el mundo.
Promoción de Ponentes y ExpertosMuestra tu experiencia y consigue keynotes, paneles y masterclasses.

Acceso Ponentes Publicar su evento gratis

La plataforma de descubrimiento de eventos B2B más confiable del mundo. Conectamos a los profesionales del sector con las conferencias, exposiciones y cumbres que importan.

Industry Events
Noticias
Organizadores de eventos
Acerca de nosotros
Nuestros servicios
Organizador Premium
Event Pro
Conviértete en Ponente
Suscribirse

Términos
Privacidad

© 2026 Industry Events Worldwide. Todos los derechos reservados.

VF96.7.

Eventos
Noticias
Análisis
Cuenta

English Français Español 中文 العربية

Eventos Noticias Análisis Organizadores

Marketing de EventosPublica, promociona y haz crecer tus eventos ante una audiencia B2B global.
Comunicado de PrensaDistribuye anuncios oficiales a profesionales del sector en todo el mundo.
Promoción de Ponentes y ExpertosMuestra tu experiencia y consigue keynotes, paneles y masterclasses.

Acceso Ponentes Publicar su evento gratis

News

Categories

Últimas
Agricultura
Cadena de Suministro
China y BRICS+
Ciberseguridad
Defensa
Energía y Movilidad
Fintech
IA y Tecnología
Robótica
Salud
Semiconductores
Startups y Capital Riesgo

Select a category to explore the latest industry reporting.

NewsWednesday, 26 August 2026

Newsletter subscribe · Free

Buscar noticias

Últimas
IA y Tecnología
Ciberseguridad
Semiconductores
Robótica
Fintech
Energía y Movilidad
Defensa
Salud
Cadena de Suministro
Startups y Capital Riesgo
China y BRICS+
Agricultura

Noticias

Salud

Las últimas noticias, anuncios y análisis del sector Salud, provenientes de las conferencias, exposiciones y cumbres que dan forma al sector.

Últimas noticias de la sección

STAT+: Are cancer patients getting too much drug?

(opens original source in a new tab)

STAT News

STAT+: Are cancer patients getting too much drug?

La plataforma de descubrimiento de eventos B2B más confiable del mundo. Conectamos a los profesionales del sector con las conferencias, exposiciones y cumbres que importan.

Moderna's stunning surge and drop, AI in scientific writing, and more biotech news from The Readout

(opens original source in a new tab)

Meghana Keshavan·21 August 2026

Scientists deploy Merck’s Ebola vaccine in DRC

(opens original source in a new tab)

STAT News

Scientists deploy Merck’s Ebola vaccine in DRC

Prostate cancer therapy, Meta glasses in hospital settings, and more health news from Morning Rounds

(opens original source in a new tab)

O. Rose Broderick·21 August 2026

Opinion: Lil Nas X’s bipolar diagnosis and the paradox of treatment

(opens original source in a new tab)

STAT News

Opinion: Lil Nas X’s bipolar diagnosis and the paradox of treatment

We continue to romanticize the symptoms of mental health problems, especially when we talk about achievement.

(opens original source in a new tab)

Rachel Docekal·21 August 2026

Focal therapy for localized prostate cancer has divided physicians. Will new data change minds?

(opens original source in a new tab)

STAT News

Focal therapy for localized prostate cancer has divided physicians. Will new data change minds?

Urologic oncologists who treat prostate cancer are split over the benefits of focal therapy compared to traditional surgery or radiation.

(opens original source in a new tab)

Annalisa Merelli·21 August 2026

Opinion: A cure for HIV would be a triumph. But it shouldn’t harm survivors

(opens original source in a new tab)

STAT News

Opinion: A cure for HIV would be a triumph. But it shouldn’t harm survivors

Long-term survivors deserve to see a cure, not fear the losses it might bring.

(opens original source in a new tab)

Ali Ahmed, Jeff Taylor,and Jeff Berry·21 August 2026

STAT+: How a Trump loyalist got the FDA nomination

(opens original source in a new tab)

STAT News

STAT+: How a Trump loyalist got the FDA nomination

What you need to know about Heidi Overton, and Erica Schwartz's first speech to CDC staff.

(opens original source in a new tab)

John Wilkerson·20 August 2026

STAT+: FDA approves Ultragenyx gene therapy

(opens original source in a new tab)

STAT News

STAT+: FDA approves Ultragenyx gene therapy

Regeneron wins ultra-rare disease drug approval, a validating win for mRNA research, and more biotech news from The Readout

(opens original source in a new tab)

Meghana Keshavan·20 August 2026

Contrasting legal decisions on gender-affirming care

(opens original source in a new tab)

STAT News

Contrasting legal decisions on gender-affirming care

Heidi Overton's rise under Trump, inside a 5-year-old brain organoid, and other health news from Morning Rounds

(opens original source in a new tab)

Theresa Gaffney·20 August 2026

STAT+: Pharmalittle: We’re reading about a Regeneron rare disease drug, an Ultragenyx gene therapy, and more

(opens original source in a new tab)

STAT News

STAT+: Pharmalittle: We’re reading about a Regeneron rare disease drug, an Ultragenyx gene therapy, and more

A Regeneron drug for an ultra-rare disease that causes bone to grow where it shouldn't won U.S. regulatory approval, capping a three-decade effort

(opens original source in a new tab)

Ed Silverman·20 August 2026

STAT+: One of the most consequential years for cancer treatment, ever

(opens original source in a new tab)

STAT News

STAT+: One of the most consequential years for cancer treatment, ever

Between success with a pancreatic cancer drug and now success with an mRNA neoantigen vaccine, it has been a banner year for developing cancer therapies.

(opens original source in a new tab)

Adam Feuerstein·20 August 2026

STAT+: Capricor Therapeutics’ Duchenne treatment is heading for an FDA rejection

(opens original source in a new tab)

STAT News

STAT+: Capricor Therapeutics’ Duchenne treatment is heading for an FDA rejection

Capricor Therapeutics is trying to stave off FDA rejection of its cell therapy for Duchenne muscular dystrophy.

(opens original source in a new tab)

Adam Feuerstein·20 August 2026

Reduce protein to increase longevity? Nutrition experts say that’s a bad idea

(opens original source in a new tab)

STAT News

Reduce protein to increase longevity? Nutrition experts say that’s a bad idea

Reducing protein intake could increase human longevity, researchers recently suggested. That's a bad idea, for several reasons, experts say.

(opens original source in a new tab)

Lauren Chan·20 August 2026

Los más leídos

STAT+: Are cancer patients getting too much drug?
Scientists deploy Merck’s Ebola vaccine in DRC
Opinion: Lil Nas X’s bipolar diagnosis and the paradox of treatment
Focal therapy for localized prostate cancer has divided physicians. Will new data change minds?
Opinion: A cure for HIV would be a triumph. But it shouldn’t harm survivors

1
2
3
4
5
6
7

Industry Events
Noticias
Organizadores de eventos
Acerca de nosotros
Nuestros servicios
Organizador Premium
Event Pro
Conviértete en Ponente
Suscribirse

Términos
Privacidad

© 2026 Industry Events Worldwide. Todos los derechos reservados.

VF96.7.

La semana en eventos de la industria, entregada cada viernes.

Un email corto. Las mejores historias de ferias, conferencias y cumbres que dan forma a los negocios mundiales. Sin relleno, sin spam, cancela en cualquier momento.

Sitio web

¿En qué sector trabaja? (opcional — nos ayuda a personalizar su resumen)